N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine

C82H98N22OS4 — CID 159288270

IUPACN-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine
SMILESCc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCCCC4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCN(C)CC4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCNCC4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCOCC4)s3)n2)c1
InChIInChI=1S/C21H26N6S.C21H25N5S.C20H24N6S.C20H23N5OS/c1-15-10-16(2)12-17(11-15)24-21-22-5-4-19(25-21)20-23-13-18(28-20)14-27-8-6-26(3)7-9-27;1-15-10-16(2)12-17(11-15)24-21-22-7-6-19(25-21)20-23-13-18(27-20)14-26-8-4-3-5-9-26;1-14-9-15(2)11-16(10-14)24-20-22-4-3-18(25-20)19-23-12-17(27-19)13-26-7-5-21-6-8-26;1-14-9-15(2)11-16(10-14)23-20-21-4-3-18(24-20)19-22-12-17(27-19)13-25-5-7-26-8-6-25/h4-5,10-13H,6-9,14H2,1-3H3,(H,22,24,25);6-7,10-13H,3-5,8-9,14H2,1-2H3,(H,22,24,25);3-4,9-12,21H,5-8,13H2,1-2H3,(H,22,24,25);3-4,9-12H,5-8,13H2,1-2H3,(H,21,23,24)
InChIKeyKZUAHEWDJYWTJU-UHFFFAOYSA-N
MW1536.11 g/mol
LogP15.81
Rot. Bonds20

About N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine

N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine (PubChem CID 159288270) has the molecular formula C82H98N22OS4 and a molecular weight of 1536.11 g/mol. Its IUPAC name is N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine.

Molecular Properties

Compound NameN-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine
PubChem CID159288270
Molecular FormulaC82H98N22OS4
Molecular Weight1536.11 g/mol
Exact Mass1534.72
IUPAC NameN-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine
SMILESCc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCCCC4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCN(C)CC4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCNCC4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCOCC4)s3)n2)c1
InChIInChI=1S/C21H26N6S.C21H25N5S.C20H24N6S.C20H23N5OS/c1-15-10-16(2)12-17(11-15)24-21-22-5-4-19(25-21)20-23-13-18(28-20)14-27-8-6-26(3)7-9-27;1-15-10-16(2)12-17(11-15)24-21-22-7-6-19(25-21)20-23-13-18(27-20)14-26-8-4-3-5-9-26;1-14-9-15(2)11-16(10-14)24-20-22-4-3-18(25-20)19-23-12-17(27-19)13-26-7-5-21-6-8-26;1-14-9-15(2)11-16(10-14)23-20-21-4-3-18(24-20)19-22-12-17(27-19)13-25-5-7-26-8-6-25/h4-5,10-13H,6-9,14H2,1-3H3,(H,22,24,25);6-7,10-13H,3-5,8-9,14H2,1-2H3,(H,22,24,25);3-4,9-12,21H,5-8,13H2,1-2H3,(H,22,24,25);3-4,9-12H,5-8,13H2,1-2H3,(H,21,23,24)
InChIKeyKZUAHEWDJYWTJU-UHFFFAOYSA-N
XLogP15.81
TPSA240.26 Ų
H-Bond Donors5
H-Bond Acceptors27
Rotatable Bonds20
Heavy Atoms109
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001536.11
LogP ≤ 515.81
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1027

Analyze N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine?
The IUPAC name of N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine (CID 159288270) is N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine.
What is the SMILES notation for N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine?
The canonical SMILES for N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine is Cc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCCCC4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCN(C)CC4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCNCC4)s3)n2)c1.Cc1cc(C)cc(Nc2nccc(-c3ncc(CN4CCOCC4)s3)n2)c1.
What is the InChIKey of N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine?
The InChIKey is KZUAHEWDJYWTJU-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H26N6S.C21H25N5S.C20H24N6S.C20H23N5OS/c1-15-10-16(2)12-17(11-15)24-21-22-5-4-19(25-21)20-23-13-18(28-20)14-27-8-6-26(3)7-9-27;1-15-10-16(2)12-17(11-15)24-21-22-7-6-19(25-21)20-23-13-18(27-20)14-26-8-4-3-5-9-26;1-14-9-15(2)11-16(10-14)24-20-22-4-3-18(25-20)19-23-12-17(27-19)13-26-7-5-21-6-8-26;1-14-9-15(2)11-16(10-14)23-20-21-4-3-18(24-20)19-22-12-17(27-19)13-25-5-7-26-8-6-25/h4-5,10-13H,6-9,14H2,1-3H3,(H,22,24,25);6-7,10-13H,3-5,8-9,14H2,1-2H3,(H,22,24,25);3-4,9-12,21H,5-8,13H2,1-2H3,(H,22,24,25);3-4,9-12H,5-8,13H2,1-2H3,(H,21,23,24).
What are the key properties of N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine?
N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine has a molecular weight of 1536.11 g/mol, XLogP of 15.81, 20 rotatable bonds, 5 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3,5-dimethylphenyl)-4-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(morpholin-4-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperazin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine;N-(3,5-dimethylphenyl)-4-[5-(piperidin-1-ylmethyl)-1,3-thiazol-2-yl]pyrimidin-2-amine is sourced from PubChem (CID 159288270), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).